Article citationsMore >>

Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY (2007). Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology; 132: 1925-1936.

has been cited by the following article:

Article

Silymarin: Insights into Properties and Therapeutic Indications

1Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

2Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt


World Journal of Nutrition and Health. 2014, Vol. 2 No. 3, 33-34
DOI: 10.12691/jnh-2-3-1
Copyright © 2014 Science and Education Publishing

Cite this paper:
Ahmed M Kabel. Silymarin: Insights into Properties and Therapeutic Indications. World Journal of Nutrition and Health. 2014; 2(3):33-34. doi: 10.12691/jnh-2-3-1.

Correspondence to: Ahmed  M Kabel, Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. Email: drakabel@gmail.com

Abstract

Silymarin is the active ingredient of milk thistle. Several studies proved that silymarin has antioxidant, anti-inflammatory and anti-cancer properties. Silymarin is widely used for treatment of hepatic and biliary disorders, renal toxicity and is recently used as adjuvant agent for treatment of cancer.

Keywords